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Abstract 
Aims/Introduction: Several lines of evidence suggest that dysregulation of the WNT 
signaling pathway is involved in the pathogenesis of type 2 diabetes. This study was 
performed to elucidate the effects of a high fat/high sucrose (HF/HS) diet on pancreatic 
islet functions in relation to modulation of WNT ligand expression in β-cells.  
Materials and Methods: Mice were fed either standard mouse chow or a HF/HS diet 
from 8 weeks of age. At 20 weeks of age, intraperitoneal glucose tolerance tests were 
performed in both groups of mice, followed by euthanasia and isolation of pancreatic 
islets. WNT-related gene expression in islets and MIN6 cells was measured by 
quantitative real-time RT-PCR. To explore the direct effects of WNT signals on 
pancreatic β-cells, MIN6 cells were exposed to recombinant mouse WNT4 protein 
(rmWNT4) for 48 h, and glucose-induced insulin secretion were measured. Furthermore, 
Wnt4 siRNAs were transfected into MIN6 cells, and cell viability and insulin secretion 
were measured in control and Wnt4 siRNA-transfected MIN6 cells.     
Results: Mice fed the HF/HS diet were heavier and their plasma glucose and insulin 
levels were higher compared with mice fed standard chow. Wnt4, Wnt5b, Ror1, and Ror2 
expression was upregulated, while Fzd4, Fzd5, Fzd6, Lrp5, and Lrp6 expression was 
downregulated in islets of mice fed the HF/HS diet. Wnt4 was the most abundantly 
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expressed WNT ligand in β-cells, and its expression was increased by the HF/HS diet. 
Although exposure to recombinant mouse WNT4 protein for 48 h did not alter glucose-
induced insulin secretion, it was significantly reduced by knockdown of Wnt4 in MIN6 
cells.  
Conclusions: We demonstrated that the HF/HS diet-induced increase of WNT4 signaling 
in β-cells is involved in augmentation of glucose-induced insulin secretion and impaired 
β-cell proliferation. These results strongly indicate an essential role of WNT4 in the 
regulation of β-cell functions in mouse pancreatic islets. 
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1. Introduction 
Surplus intake of dietary fat and sugar is extremely relevant to the pathogenesis of 
type 2 diabetes. Mice fed a high fat/high sucrose (HF/HS) diet develop insulin resistance 
and hyperinsulinemia, and exhibit hyperplasia of pancreatic β-cells (1). The susceptibility 
and phenotype vary depending on the genetic background, and it is feasible that 
accumulation of visceral fat contributes to the development of insulin resistance. 
However, the precise mechanisms by which excessive intake of a HF/HS diet causes β-
cell hyperplasia and hyperinsulinemia remain to be elucidated.  
WNT signaling pathways play critical roles in the differentiation, proliferation, death, 
and function of various cell types (2,3,4). Aberrant WNT signaling is associated with 
various diseases including cancer (5, 6). Dysregulation of the WNT signaling pathway is 
also involved in the pathogenesis of type 2 diabetes in relation to expression of TCF7L2, 
the most responsible gene for type 2 diabetes, which encodes a key component of the 
WNT signaling pathway (7).  
The Wnt gene was first identified in 1982 and is named the Int gene in mice (8). 
Subsequently, the Drosophila int1 homolog was found to be wingless. As a result, both 
genes were recognized as the Wnt gene (9). WNTs are a large family of 19 secreted 
carbohydrate- and lipid-modified proteins including Wnt1, Wnt2, Wnt2b (Wnt13), Wnt3, 
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Wnt3a, Wnt4, Wnt5a, Wnt5b, Wnt6, Wnt7a, Wnt7b, Wnt8a, Wnt8b, Wnt9a (Wnt14), 
Wnt9b (Wnt14b), Wnt10a, Wnt10b, Wnt11, and Wnt16 (10).  
The most studied WNT ligand is WNT 3a. The addition of purified WNT3a protein 
to cultured β-cells or islets promotes expression of Pitx2, a direct target of WNT signaling, 
as well as Cyclin D2, an essential regulator of the β-cell cycle and proliferation (11). 
WNT4 completely blocks WNT3a-stimulated β-cell growth and insulin secretion (12). In 
the present study, we examined the putative relevance of WNT4 signaling to the 
pathogenesis of diabetes and insulin resistance under a HF/HS condition in mice. 
 
2. Materials and methods 
2.1. Animals 
Male C57BL/6 mice were purchased from Nippon CLEA (Shizuoka, Japan). They 
were housed in standard cages with free access to water under a 12 h light/12 h dark cycle 
from 8 to 20 weeks of age, and fed either control chow (347 kcal/100 g, 12% fat and 28% 
protein; Nippon CLEA) or a HF/HS diet (592 kcal/100 g, 70% fat, 14% sucrose, 3% other 
carbohydrates, and 13% protein; Oriental Yeast, Tokyo, Japan). All mice were treated 
according to the guidelines for the care and use of laboratory animals of Kurume 
University School of Medicine based on the National Institutes of Health Guidelines. All 
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efforts were made to ensure minimal suffering. 
2.2. Experimental protocols for mice fed control chow or the HF/HS diet 
At 20 weeks of age, an intraperitoneal glucose tolerance test was performed by 
injection of glucose (1 g/kg body weight dissolved at 10 v/v% in distilled water) 
intraperitoneally after overnight fasting. Blood was obtained from the tail vein, and 
glucose concentrations were measured by the glucose dehydrogenase method using Free 
Style (Nipro, Osaka, Japan) at 0, 30, 60, and 120 min after glucose injection. Then, all 
mice were euthanized under anesthesia for the following experiments. Blood samples 
were collected from the inferior vena cava and centrifuged (3000 g, 10 min), and sera 
were collected and stored at -80°C until assaying the insulin concentrations. Pancreatic 
islets were isolated from the harvested pancreas by collagenase digestion as described 
previously (13).  
The pancreas was fixed in 4% paraformaldehyde and embedded in paraffin. Sections 
of the pancreas were incubated with a rabbit polyclonal antibody against WNT4 
(ab91226; Abcam, Cambridge, UK) at a dilution of 1:20 for 24 h. The sections were then 
washed and incubated with fluorochrome-conjugated goat anti-rabbit IgG H&L 
(ab150078; Abcam) for 1 h at room temperature. Immunostaining of insulin, glucagon, 
and somatostatin was performed using a guinea pig polyclonal anti-insulin antibody 
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(ab7842; Abcam), goat polyclonal anti-glucagon (N-17) antibody (sc-7780; Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), and goat polyclonal anti-somatostatin antibody 
(sc-7819; Santa Cruz Biotechnology), respectively, followed by corresponding 
fluorochrome-conjugated secondary antibodies (Abcam). 
2.3. Protocols for the culture and incubation experiment using MIN-6 cells 
The MIN6 pancreatic β-cell line, which was kindly provided by Prof. Jun-ichi 
Miyazaki (Osaka University) (14), was maintained in Dulbecco’s modified Eagle’s 
medium (DMEM) (25 mmol/L glucose) containing 10% (v/v) fetal bovine serum, 50 
μmol/L β-mercaptoethanol, 50 U/ml penicillin, and 50 μg/ml streptomycin at 37°C with 
5% CO2. Twenty-four hours before transfection, the cells were trypsinized and cell 
numbers were counted. Then, they were transferred and placed in culture medium. Wnt4 
siRNAs (Thermo Scientific, Lafayette, CO, USA) and a control siRNA were transfected 
in accordance with the manufacturer’s instructions at a working concentration of 50 
nmol/L using Lipofectamine RNAiMax (Invitrogen, Carlsbad, CA, USA). Transfected 
cells were cultured for 48 h until subsequent experiments. 
   In another series of experiments, recombinant mouse WNT4 (rmWNT4; R&D 
Systems, Abingdon, UK) was added to the incubation medium at concentrations of 0.2 or 
0.5 μg/ml. The cells were then cultured for 48 h until subsequent experiments. 
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On the day of the experiment to measure insulin secretion, MIN6 cells were harvested 
and seeded in 24-well plates at a density of 1.5 × 105 cells per well. The cells were cultured 
for 72 h and pre-incubated at 37°C for 60 min in Hepes-Krebs buffer (118.4 mmol/L NaCl, 
4.7 mmol/L KCl, 1.2 mmol/L KH2PO4, 2.4 mmol/L CaCl2, 1.2 mmol/L MgSO4, 20 
mmol/L NaHCO3, 2.2 mmol/L glucose, and 10 mmol/L Hepes) containing 0.5% (w/v) 
bovine serum albumin. Then, Hepes-Krebs buffer was changed into the one containing 
22 mmol/L glucose, and incubated for the next 60 min in . Culture media containing either 
2.2 or 22 mmol/L glucose were collected and stored at -80°C until assaying the insulin 
concentrations.  
A stock solution was prepared by dissolving palmitate (R&D Systems Inc.) in 95% 
ethanol to 25 mmol/L. This solution was diluted in glucose-free DMEM containing 2% 
fatty acid-free bovine serum albumin (Gibco, Grand Island, NY, USA) to 2.5 mmol/L and 
then mixed at 37°C for 1 h. The final concentration of palmitate in the medium was 
adjusted to 0.4 mmol/L. After 24 h of exposure to palmitate, cell lysates were subjected 
to experiments for measurements of Wnt4 and Chop gene expression. 
2.4. Measurements of serum insulin concentration, gene expression and cell 
proliferatoin 
Insulin concentrations in serum were measured by an ultrasensitive mouse insulin 
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ELISA kit (Shibayagi, Gunma, Japan). Insulin resistance was evaluated by homeostatic 
model assessment-insulin resistance (HOMA-IR) [fasting blood glucose (mg/dL) × 
fasting blood insulin (µU/mL) / 405]. 
Total RNA in pancreatic islets was extracted with RNA-Bee (Cosmo Bio, Tokyo, 
Japan), and that in MIN-6 cells was extracted with an RNeasy Micro kit (Qiagen, CA). A 
PrimeScript RT Reagent Kit with gDNA Eraser was employed to reverse transcribe the 
total RNA to cDNA (PR047A; Takara, Kusatsu, Japan). Subsequently, quantitative real-
time RT-PCR was performed with SYBR Premix Ex Taq II (RR420A; Takara) using a 
StepOnePlus (Applied Biosystems, Foster City, CA, USA). The PCR cycling conditions 
were 30 s at 95°C, followed by 40 cycles of 5 s at 95°C and 31 s at 60°C. The expression 
of individual genes was normalized to either Gapdh expression for pancreatic islets or 
Tbp expression for MIN-6 cells. 
Cell proliferation was measured by Cell Counting Kit-8 (Dojindo Laboratories, 
Kumamoto, Japan) in accordance with the manufacturer’s instructions. Absorbance at 
450 nm was determined by a microplate reader (Bio Rad, Hercules, CA, USA). Cell 
viability was calculated as follows: viable cell number (%) = (mean absorbency in test 
wells) / (mean absorbency in control wells) × 100.  
2.5. Statistical analysis 
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All statistical analyses were performed using SPSS Statistics Ver. 23 (IBM Corp. NY). 
Statistical significance was determined by the Mann-Whitney U-test. Data are presented 
as means ± standard deviation (S.D.). A p-value of less than 0.05 was considered to be 
statistically significant. 
 
3. Results 
Mice fed the HF/HS diet were heavier and exhibited higher fasting and post-load 
glucose levels at 20 weeks of age compared with mice maintained on standard chow (Fig. 
1A, B). Additionally, fasting plasma insulin levels were significantly more elevated in 
mice fed the HF/HS diet than in those fed standard chow (Fig. 1C). HOMA-IR in mice 
fed the HF/HS diet was significantly higher than that in those fed standard chow (Fig. 
1D). Insulin immunostaining revealed hypertrophic islets in the pancreas of 20-week-old 
mice fed the HF/HS diet (Fig. 1E, F). However, little difference was seen in the number 
and distribution of glucagon-positive α-cells in the islets regardless of diet (Fig. 1G, H). 
The expression of insulin genes in isolated islets was assessed by quantitative real-time 
RT-PCR at 20 weeks of age. However, no significant difference was observed in the 
relative expression levels of Ins1 or Ins2 (Fig. 1I) between mice fed the HF/HS diet or 
standard chow. 
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   We next analyzed the expression of WNT pathway-related genes in isolated islets 
(Fig. 2). Seven of the 19 WNT ligand family member genes were expressed at detectable 
levels in islets obtained from 20-week-old mice (Fig. 2A). As summarized in Table 1, the 
lowest cycle threshold value was obtained for Wnt4. Wnt4 and Wnt5b expression was 
upregulated in islets of mice fed the HF/HS diet compared with standard chow-fed mice 
(Fig. 2A). In contrast, HF/HS diet-fed mice displayed diminished Wnt2b, Wnt11, and 
Wnt14 expression in islets (Fig. 2A). We analyzed the expression of genes associated with 
WNT signaling, revealing that nine of the 10 known Fzd receptor genes were expressed 
in the islets. HF/HS diet-fed mice showed notably lower Fzd4, Fzd5, and Fzd6 expression 
levels compared with mice fed standard chow (Fig. 2B). Expression of the two co-
receptors, Lrp5 and Lrp6, was also decreased in islets obtained from HF/HS diet-fed mice 
(Fig. 2C). In contrast, significant increases of Ror1 and Ror2 were observed in islets of 
HF/HS diet-fed mice (Fig. 2D). 
Immunostaining of WNT4 and insulin in serial pancreas sections from 20-week-old 
mice fed standard chow revealed that non-β-cells located at the periphery of islets highly 
produced WNT4 (Fig. 2E–G). Interestingly, compared with islets from mice fed standard 
chow, WNT4 staining was much stronger in mice fed the HF/HS diet, especially in the 
central area of islets (Fig. 2H, I). These results suggested that the HF/HS diet increased 
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Wnt4 expression in β-cells, prompting us to assess a possible direct effect of fatty acids 
on Wnt4 gene expression. However, as shown in Fig. 2J, treatment with palmitate led to 
a significant reduction of Wnt4 expression in MIN6 cells, suggesting that other factor(s) 
related to insulin resistance may be involved in the upregulation of WNT4 under a HF/HS 
diet in vivo. Reciprocal induction of the transcription factor CHOP by the saturated fatty 
acid indicated aggravation of endoplasmic reticulum (ER) stress due to lipotoxicity in 
MIN6 cells. 
To identify cells that were strongly positive for WNT4, we stained three serial 
sections with anti-glucagon, anti-WNT4, and anti-somatostatin antibodies, respectively 
(Fig. 3A–C). Most cells showing strong positivity for WNT4 were glucagon-containing 
cells. In contrast, somatostatin-containing cells did not show strong staining for WNT4 
(Fig. 3D, E). 
Exposure of MIN6 cells to rmWNT4 protein for 48 h did not affect glucose-induced 
insulin secretion (Fig. 4A). The reduction of Wnt4 expression by transfecting MIN6 cells 
with Wnt4-specific siRNAs was confirmed by quantitative RT-PCR (Fig. 4B). The 
numbers of viable cells were unchanged by knockdown of Wnt4 expression (Fig. 4C). 
Although there was no effect on the expression of insulin genes (Fig. 4D, E), glucose-
induced secretion of insulin was significantly reduced by Wnt4 knockdown in MIN6 cells 
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(Fig. 4F). 
 
4. Discussion 
   Various lines of evidence indicate that β-catenin/TCF7L2-dependent WNT signaling 
plays crucial roles in pancreas development, islet cell proliferation, and insulin secretion. 
Cre-mediated β-cell-specific deletion of β-catenin inhibits insulin secretion and glucose 
intolerance in mice. It was suggested that the lack of β-catenin might delay β-cell 
maturation, resulting in abnormal glycemia and insulinemia owing to β-cell dysfunction 
(15). Moreover, the reduction of β-catenin in β-cell lines using siRNA or pyrvinium, an 
inhibitor of the β-catenin signaling pathway, attenuates glucose- and KCl-stimulated 
insulin secretion (16).  
Depending on their functions, WNT ligands are classified into two categories. WNT1, 
WNT2, WNT2b, WNT3, WNT3a, WNT7a, WNT8, WNT8b, and WNT10a belong to the 
canonical signaling pathway, while WNT4, WNT5a, and WNT11 belong to the non-
canonical signaling pathway (17). Former studies of WNT ligands have focused on the 
role of WNT3a that activates the canonical β-catenin signaling in β-cells. WNT4 as a non-
canonical ligand is known to be involved in kidney and gonadal gland development (18, 
19). It has been recently reported that expression of Wnt4 is abundant in pancreatic islets 
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and upregulated in insulin-resistant model mice (20). However, the precise role of Wnt4 
in diabetes and insulin resistance has not been elucidated so far. In pancreatic islets and 
INS-1 cells, WNT4 inhibits WNT3a-mediated increases in proliferation and glucose-
stimulated insulin secretion (12). The abundance of WNT4 in pancreatic islets and its 
increase in response to insulin resistance implies potential roles of WNT4 in pancreatic 
islets independent of WNT3a.  
Mice fed the HF/HS diet exhibited obesity, insulin resistance, and glucose intolerance. 
HF/HS diet-fed mice had larger pancreatic islets that predominantly consisted of β-cells. 
In line with former reports (21, 22), Wnt4 was the most abundantly expressed WNT-
related gene in the islets. Consistent with a study by Bowen et al. [9], immunostaining 
revealed that the protein level of WNT4 was greater in α-cells than in β-cells in the 
pancreas of standard chow-fed mice. We also found that the HF/HS diet increased WNT4 
expression in β-cells to a comparable level as that in α-cells. These observations suggest 
that WNT4 plays an essential role in β-cell proliferation or alterations of the insulin 
secretory response induced by the HF/HS diet.  
Next, we assessed the effect of Wnt4 knockdown on MIN6 cell proliferation using 
specific siRNAs. Wnt4 knockdown resulted in no significant difference in the number of 
viable cells, suggesting that WNT4 does not affect the regulation of MIN6 cell 
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proliferation. In rat INS-1 cells, the role of endogenous WNT4 in cell proliferation has 
been controversial (12, 23). Overall, the role of endogenously expressed WNT4 may vary 
depending on the cell type.  
Wnt4 knockdown did not affect Ins1 or Ins2 expression. In contrast, glucose-induced 
insulin secretion was significantly suppressed in MIN6 cells treated with Wnt4-specific 
siRNAs, suggesting that WNT4 may be involved in glucose-induced vesicle transport of 
insulin in MIN6 cells. Therefore, upregulation of Wnt4 expression may be associated with 
compensatory enhancement of the insulin secretory response, but not insulin biosynthesis, 
in diet-induced insulin-resistant mice. In line with former reports (12, 23), the addition of 
exogenous WNT4 did not exert a notable effect on insulin secretion. Although its precise 
mechanisms remain unknown, it is feasible that WNT4 is secreted from β-cells and acts 
as a ligand for its receptor in an autocrine/paracrine manner, thereby prohibiting 
additional ligand binding.  
WNT4 dominantly produced in β-cells under the HF-HS condition might play a role 
in glucose-induced insulin secretion. Non-canonical WNT signals include calcium release 
from the ER and the resultant elevation of intracellular calcium, which may augment 
insulin release from β-cells. However, to explicate the precise mechanism of the WNT4 
action in β-cells, further studies are required. The reduced expression of Lrp5 and Lrp6, 
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which are co-receptors for transduction of β-catenin-dependent signals, and increased 
expression of Ror1 and Ror2, which are co-receptors involved in non-β-catenin-
dependent WNT signaling, likely shift the balance between canonical and non-canonical 
signals toward the latter. The altered expression of WNT co-receptors may be involved 
in the diabetogenic effect of the HF/HS diet because LRP5-deficient mice also exhibit 
impaired glucose tolerance (24). 
 
5. Conclusion 
   This study demonstrated that long term feeding with a HF/HS diet profoundly altered 
the expression of WNT signaling genes in pancreatic islets, and that expression of Wnt4 
was significantly increased in β-cells. WNT4 signaling plays a pivotal role in regulating 
glucose-induced insulin secretion. Comprehensive understanding of the WNT4 signaling 
pathway may facilitate development of new therapeutics for type 2 diabetes.  
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Figure legends 
Figure 1. Body weight (A), fasting and post-load plasma glucose concentrations (B), 
fasting plasma insulin levels (C), and HOMA-IR (D) of 20-week-old mice fed standard 
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chow (open column, circle) or the high fat/high sucrose (HF/HS) diet (closed column, 
square). Mean ± S.D., *p<0.05, **p<0.01, n=6. Immunostaining of insulin (E, F) and 
glucagon (G, H) in islets of 20-week-old mice fed standard chow (E, G) or the HF/HS 
diet (F, H). Scale bars indicate 100 μm in E and F, and 50 μm in G and H. Relative 
expression of Ins1 and Ins2 (I) in islets of 20-week-old mice fed standard chow (open 
column) or the HF/HS diet (closed column). Mean ± S.D., n = 6.  
 
Figure 2. Relative expression of WNT ligands (A), Frizzled receptors (B), non-Frizzled 
WNT receptors (C), and co-receptors (D) in the islets of mice fed the HF/HS diet. Data 
are shown as ratios to those in mice fed standard chow. Means ± S.D., *p<0.05, **p<0.01 
vs. the values of mice fed standard chow. Immunostaining of WNT4 (E) and insulin (F), 
and a merged image (G) in an islet of a mouse fed standard chow. Immunostaining of 
WNT4 in islets of mice fed standard chow (H) or the HF/HS diet (I). Scale bars indicate 
50 μm. Relative expression of Wnt4 and Chop in MIN6 cells treated with or without 0.4 
mM palmitate for 24 h. Means ± S.D., *p<0.05, **p<0.01 (J). 
 
Figure 3. Immunostaining of WNT4 (A), glucagon (B), and somatostatin (D) in serial 
sections of an islet of a 20-week-old mouse fed standard chow. Merged image of Wnt4 
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and glucagon staining (C). Merged image of Wnt4 and somatostatin staining (E). 
GCG; glucagon, SST; somatostatin. 
 
Figure 4. Effect of recombinant mouse WNT4 on glucose-induced insulin secretion in 
MIN6 cells (A), n=4. Knockdown of Wnt4 expression by specific siRNAs (B), n=4. Effect 
of Wnt4 knockdown on the number of viable MIN6 cells (C), n=3, expression of Ins1 (D) 
and Ins2 (E), and glucose-induced insulin secretion (F), n=4. Means ± S.D. *p<0.05, 
**p<0.01 vs. control siRNA. 
 
Table 1. Cycle threshold (CT) values in real-time RT-PCR of WNT ligand, receptor, and 
co-receptor genes. 
